Sodium pentaborate pentahydrate and sodium perborate tetrahydrate can inhibit breast cancer progression but also have the potential to cause side effects by stimulating PD-1/PD-L1 expression and inhibiting the release of cytolytic cytokines [152]. This evidence concerns the gene CD274 and breast carcinoma.